191 related articles for article (PubMed ID: 28105886)
21. Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition case.
Lobefalo F; Bignardi M; Reggiori G; Tozzi A; Tomatis S; Alongi F; Fogliata A; Gaudino A; Navarria P; Cozzi L; Scorsetti M; Mancosu P
Radiat Oncol; 2013 Jul; 8():176. PubMed ID: 23837942
[TBL] [Abstract][Full Text] [Related]
22. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of geometrical uncertainties on localized prostate radiotherapy of patients with bilateral metallic hip prostheses using 3D-CRT, IMRT and VMAT: A planning study.
Soda R; Hatanaka S; Hariu M; Shimbo M; Yamano T; Nishimura K; Kondo S; Utsumi N; Takahashi T
J Xray Sci Technol; 2020; 28(2):243-254. PubMed ID: 31985486
[TBL] [Abstract][Full Text] [Related]
24. Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma.
Filippi AR; Ciammella P; Piva C; Ragona R; Botto B; Gavarotti P; Merli F; Vitolo U; Iotti C; Ricardi U
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):370-5. PubMed ID: 24613810
[TBL] [Abstract][Full Text] [Related]
25. Deformable image registration and interobserver variation in contour propagation for radiation therapy planning.
Riegel AC; Antone JG; Zhang H; Jain P; Raince J; Rea A; Bergamo AM; Kapur A; Potters L
J Appl Clin Med Phys; 2016 May; 17(3):347-357. PubMed ID: 27167289
[TBL] [Abstract][Full Text] [Related]
26. Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum.
Filippi AR; Meregalli S; DI Russo A; Levis M; Ciammella P; Buglione M; Guerini AE; De Marco G; De Sanctis V; Vagge S; Ricardi U; Simontacchi G;
Radiat Oncol; 2020 Mar; 15(1):62. PubMed ID: 32164700
[TBL] [Abstract][Full Text] [Related]
27. A comparison of radiation treatment plans using IMRT with helical tomotherapy and 3D conformal radiotherapy for nasal natural killer/T-cell lymphoma.
Tomita N; Kodaira T; Tachibana H; Nakamura T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A
Br J Radiol; 2009 Aug; 82(981):756-63. PubMed ID: 19366734
[TBL] [Abstract][Full Text] [Related]
28. Radiation-induced second malignancies after involved-node radiotherapy with deep-inspiration breath-hold technique for early stage Hodgkin Lymphoma: a dosimetric study.
Schneider U; Sumila M; Robotka J; Weber D; Gruber G
Radiat Oncol; 2014 Feb; 9():58. PubMed ID: 24548307
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric comparison of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for left-sided chest wall and lymphatic irradiation.
Kivanc H; Gultekin M; Gurkaynak M; Ozyigit G; Yildiz F
J Appl Clin Med Phys; 2019 Dec; 20(12):36-44. PubMed ID: 31680445
[TBL] [Abstract][Full Text] [Related]
30. Importance of PET/CT scan use in planning radiation therapy for lymphoma.
Milana MA; Marko E; Miroslav L; Tihomir D
Asian Pac J Cancer Prev; 2015; 16(5):2051-4. PubMed ID: 25773849
[TBL] [Abstract][Full Text] [Related]
31. Interobserver Variations in Target Delineation in Intensity-Modulated Radiation Therapy for Nasopharyngeal Carcinoma and its Impact on Target Dose Coverage.
Liu X; Huang H; Zhu C; Gan Q; Jiang H; Liu P; Qi X; Fan F; Xiao J; Pang Q; Lu Z; Lu H
Technol Cancer Res Treat; 2023; 22():15330338231169592. PubMed ID: 37098688
[TBL] [Abstract][Full Text] [Related]
32. A Quality Control Study on Involved Node Radiation Therapy in the European Organisation for Research and Treatment of Cancer/Lymphoma Study Association/Fondazione Italiana Linfomi H10 Trial on Stages I and II Hodgkin Lymphoma: Lessons Learned.
Aleman BMP; Ricardi U; van der Maazen RWM; Meijnders P; Beijert M; Boros A; Izar F; Janus CPM; Levis M; Martin V; Specht L; Corning C; Clementel E; Raemaekers JM; André MP; Federico M; Fortpied C; Girinsky T
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):664-674. PubMed ID: 37179034
[TBL] [Abstract][Full Text] [Related]
33. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?
De Sanctis V; Bolzan C; D'Arienzo M; Bracci S; Fanelli A; Cox MC; Valeriani M; Osti MF; Minniti G; Chiacchiararelli L; Enrici RM
Radiat Oncol; 2012 Aug; 7():129. PubMed ID: 22857015
[TBL] [Abstract][Full Text] [Related]
34. Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin's disease.
Koeck J; Abo-Madyan Y; Eich HT; Stieler F; Fleckenstein J; Kriz J; Mueller RP; Wenz F; Lohr F
Strahlenther Onkol; 2012 Aug; 188(8):653-9. PubMed ID: 22740169
[TBL] [Abstract][Full Text] [Related]
35. Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients.
Girinsky T; Aupérin A; Ribrag V; Elleuch M; Fermé C; Bonniaud G; Ruelle C; Alberini JL; Celebic A; Edeline V
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1047-1052. PubMed ID: 25035208
[TBL] [Abstract][Full Text] [Related]
36. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
37. Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma.
Paumier A; Ghalibafian M; Beaudre A; Ferreira I; Pichenot C; Messai T; Lessard NA; Lefkopoulos D; Girinsky T
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):199-205. PubMed ID: 21481723
[TBL] [Abstract][Full Text] [Related]
38. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma.
Hoppe BS; Flampouri S; Su Z; Latif N; Dang NH; Lynch J; Joyce M; Sandler E; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):449-55. PubMed ID: 22386373
[TBL] [Abstract][Full Text] [Related]
39. Impact of target volume segmentation accuracy and variability on treatment planning for 4D-CT-based non-small cell lung cancer radiotherapy.
Martin S; Johnson C; Brophy M; Palma DA; Barron JL; Beauchemin SS; Louie AV; Yu E; Yaremko B; Ahmad B; Rodrigues GB; Gaede S
Acta Oncol; 2015 Mar; 54(3):322-32. PubMed ID: 25350526
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of 3D-CRT, IMRT and VMAT radiotherapy plans for left breast cancer based on clinical dosimetric study.
Liu H; Chen X; He Z; Li J
Comput Med Imaging Graph; 2016 Dec; 54():1-5. PubMed ID: 27838084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
